Hip replacement stem under review: 5-Year safety and performance study
NCT ID NCT04943328
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the safety and performance of a cemented hip stem (TrendHip®) in 119 people who had hip replacement surgery. It tracks pain, function, and quality of life for up to 5 years after surgery. The goal is to confirm the device works well in everyday use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
119 people
The number who actually took part.
- Started
-
Oct 2021
- Expected to finish
-
May 2028
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion: Inclusion criteria * Patient older than 18 years. * Patient who undergo / underwent a hip arthroplasty with cemented TrendHip® femoral stem according to the indications for implantation specified in the Instructions for Use. * Patient not opposing participation in the study. Exclusion: Exclusion criteria * Patient with shortened life expectancy. * The patient is unable to commit to the planned follow-up period.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Coxarthrosis; post-traumatic are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St. Franziskus-Hospital
Ahlen, North Rhine-Westphalia, 59227, Germany
-
St. Marien-Hospital
Mülheim, 45468, Germany
-
St. Vincenz Hospital Brakel
Brakel, 33034, Germany
-
radprax Krankenhaus Plettenberg GmbH
Plettenberg, 58840, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new ankle? researchers track 400 people with an implant meant to restore movement
- Can a Job-Focused rehab program keep arthritis patients employed?
- Hip surgery pain targeted with nerve block in new trial
- Do rheumatic diseases quietly damage the Eye's oil glands?
- Hidden kidney damage may lurk in rheumatoid arthritis patients
- Can a new injection calm rheumatoid arthritis? an early trial puts ZB002 to the test